Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles

Experimental Eye Research

Volumn 83, Issue 2, 2006, Pages 304-314

  McKechnie, Nicol M ^a   King, Benjamin C R ^a   Fletcher, Emma ^a   Braun, Gabriele ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

fas ligand; hr44; lysosome related organelles; microvesicles; secretory lysosomes

Indexed keywords

FAS LIGAND; GAMMA INTERFERON;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CILIARY BODY; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; ENDOCYTOSIS; EYE INFLAMMATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IRIS; LYSOSOME; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SECRETORY VESICLE; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CILIARY BODY; EPITHELIAL CELLS; EYE; EYE PROTEINS; FAS LIGAND PROTEIN; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON TYPE II; IRIS; LYSOSOMES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; PIGMENT EPITHELIUM OF EYE; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTORS;

EID: 33744947804     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.11.028     Document Type: Article

References (46)

1. Abrahams V.M., Straszewski-Chavez S.L., Guller S., and Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Human Reprod. 10 (2004) 55-63
2. Andreola G., Rivoltini L., Castelli C., Huber V., Perego P., Deho P., Squarcina P., Accornero P., Lozupone F., Lugini L., Stringaro A., Molinari A., Arancia G., Gentile M., Parmiani G., and Fais S. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195 (2002) 1303-1316
3. Blott E.J., and Griffiths G.M. Secretory lysosomes. Nat. Rev. Mol. Cell. Biol. 3 (2002) 122-131
4. Blott E.J., Bossi G., Clark R., Zvelebil M., and Griffiths G.M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114 (2001) 2405-2416
5. Braun G., McKechnie N.M., and Gürr W. Molecular and immunological characterisation of hr44, a human ocular component immunologically crossreactive with antigen Ov39 of Onchocerca volvulus. J. Exp. Med. 182 (1995) 1121-1132
6. Chiou S.H., Liu J.H., Hsu W.M., Chen S.S., Chang S.Y., Juan L.J., Lin J.C., Yang Y.T., Wong W.W., Liu C.Y., Lin Y.S., Liu W.T., and Wu C.W. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J. Immunol. 167 (2001) 4098-4103
7. Collier L.L., Prieur D.J., and King E.J. Ocular melanin pigmentation anomalies in cats, cattle, mink, and mice with Chediak-Higashi syndrome: histologic observations. Curr. Eye Res. 3 (1984) 1241-1251
8. Feng L., Novak E.K., Hartnell L.M., Bonifacino J.S., Collinson L.M., and Swank R.T. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes. Blood 99 (2002) 1651-1658
9. Ferguson T.A., and Green D.R. Fas-ligand and immune privilege: the eyes have it. Cell Death Differ. 8 (2001) 771-772
10. Frangsmyr L., Baranov V., Nagaeva O., Stendahl U., Kjellberg L., and Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placentas: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Human Reprod. 11 (2004) 35-41
11. Goud B. How Rab proteins link motors to membranes. Nat. Cell Biol. 4 (2002) 75-77 [comment]
12. Gregory M.S., Repp A.C., Holhbaum A.M., Saff R.R., Marshak-Rothstein A., and Ksander B.R. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 169 (2002) 2727-2735
13. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
14. Griffiths G. What's special about secretory lysosomes?. Seminars Cell Dev. Biol. 13 (2002) 279-284
15. Griffiths G.M. Albinism and immunity: what's the link?. Curr. Mol. Med. 2 (2002) 479-483
16. Haddad E.K., Wu X., Hammer III J.A., and Henkart P.A. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol. 152 (2001) 835-842
17. Huizing M., Anikster Y., and Gahl W.A. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic 1 (2000) 823-835
18. Ito M., Hashimoto K., and Organisciak D.T. Ultrastructural, histochemical and biochemical studies of the melanin metabolism in pallid mouse eye. Curr. Eye Res. 2 (1982) 13-28
19. Jodo S., Xiao S., Hohlbaum A., Strehlow D., Marshak-Rothstein A., and Ju S.T. Apoptosis-inducing membrane vesicles. A novel agent with unique properties. J. Biol. Chem. 276 (2001) 39938-39944
20. Kaestel C.G., Madsen H.O., Prause J.U., Jorgensen A., Liang Y., la Cour M., Lui G.M., Odum N., Nissen M.H., and Ropke C. Lack of FasL expression in cultured human retinal pigment epithelial cells. Exp. Clin. Immunogenet. 18 (2001) 34-41
21. Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S., Yoshino K., Okumura K., and Yagita H. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182 (1995) 1777-1783
22. McKechnie N.M., Braun G., Kläger S., Connor V., Taylor D.W., Alexander R., and Gilbert C.E. Immunological crossreactivity in the pathogenesis of ocular onchocerciasis. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2888-2902
23. McKechnie N.M., Gürr W., and Braun G. Immunization with the cross-reactive antigens Ov39 from Onchocerca volvulus and hr44 from human retinal tissues induces ocular pathology and activates retinal microglia. J. Infect. Dis. 176 (1997) 1334-1343
24. McKechnie N.M., Copland D., and Braun G. Hr44 secreted with exosomes: loss from ciliary epithelium in response to inflammation. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2650-2656
25. McNicol A., and Israels S.J. Platelet dense granules: structure, function and implications for haemostasis. Thromb. Res. 95 (1999) 1-18
26. Menasche G., Pastural E., Feldmann J., Certain S., Ersoy F., Dupuis S., Wulffraat N., Bianchi D., Fischer A., Le Deist F., and de Saint Basile G. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 25 (2000) 173-176
27. Novak E.K., and Swank R.T. Lysosomal dysfunctions associated with mutations at mouse pigment genes. Genetics 92 (1979) 189-204
28. Orlow S.J. Melanosomes are specialized members of the lysosomal lineage of organelles. J. Invest. Dermatol. 105 (1995) 3-7
29. Page L.J., Darmon A.J., Uellner R., and Griffiths G.M. L is for lytic granules: lysosomes that kill. Biochim. Biophys. Acta 1401 (1998) 146-156
30. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., Slot J.W., and Geuze H.J. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173 (1991) 1099-1109
31. Rezai K.A., Semnani R.T., Farrokh-Siar L., Hamann K.J., Patel S.C., Ernest J.T., and van Seventer G.A. Human fetal retinal pigment epithelial cells induce apoptosis in allogenic T-cells in a Fas ligand and PGE2 independent pathway. Curr. Eye Res. 18 (1999) 430-439
32. Robison Jr. W.G., Kuwabara T., and Cogan D.G. Lysosomes and melanin granules of the retinal pigment epithelium in a mouse model of the Chediak-Higashi syndrome. Invest. Ophthalmol. Vis. Sci. 14 (1975) 312-317
33. Sano Y., Yamada J., Ishino Y., Adachi W., Kawasaki S., Suzuki T., Kinoshita S., Okuyama T., and Azuma N. Non-cleavable mutant Fas ligand transfection of donor cornea abrogates ocular immune privilege. Exp. Eye Res. 75 (2002) 475-483
34. Seabra M.C., Ho Y.K., and Anant J.S. Deficient geranylgeranylation of Ram/Rab27 in choroideremia. J. Biol. Chem. 270 (1995) 24420-24427
35. Shiraki K., Tsuji N., Shioda T., Isselbacher K.J., and Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6420-6425
36. Stinchcombe J.C., and Griffiths G.M. Regulated secretion from hemopoietic cells. J. Cell Biol. 147 (1999) 1-6
37. Stinchcombe J.C., Barral D.C., Mules E.H., Booth S., Hume A.N., Machesky L.M., Seabra M.C., and Griffiths G.M. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J. Cell Biol. 152 (2001) 825-834
38. Stinchcombe J., Bossi G., and Griffiths G.M. Linking albinism and immunity: the secrets of secretory lysosomes. Science 305 (2004) 55-59
39. Stokes T.A., Rymaszewski M., Arscott P.L., Wang S.H., Bretz J.D., Bartron J., Baker J.R.J., Fiedler P., Schaetzlein C.E., Eibel H., Papoff G., Stassi G., De Maria R., Giordano C., Galluzzo A., Bagnasco M., Ruberti G., and Testi R. Constitutive expression of FasL in thyrocytes. Science 279 (1998) 2015a
40. Suda T., Hashimoto H., Tanaka M., Ochi T., and Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp. Med. 186 (1997) 2045-2050
41. Sugita S., and Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T-cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198 (2003) 161-171
42. Swank R.T., Novak E.K., McGarry M.P., Rusiniak M.E., and Feng L. Mouse models of Hermansky Pudlak syndrome: a review. Pig. Cell Res. 11 (1998) 60-80
43. Swank R.T., Novak E.K., McGarry M.P., Zhang Y., Li W., Zhang Q., and Feng L. Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pig. Cell Res. 8 (2000) 59-67
44. Tanaka M., Itai T., Adachi M., and Nagata S. Downregulation of Fas ligand by shedding. Nat. Med. 4 (1998) 31-36
45. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., and Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166 (2001) 7309-7318
46. Williams M.A., Pinto L.H., and Gherson J. The retinal pigment epithelium of wild type (C57BL/6J +/+) and pearl mutant (C57BL/6J pe/pe) mice. Invest. Ophthalmol. Vis. Sci. 26 (1985) 657-669